135 related articles for article (PubMed ID: 33407510)
1. Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling.
Hang C; Zhao S; Wang T; Zhang Y
Cancer Cell Int; 2021 Jan; 21(1):25. PubMed ID: 33407510
[TBL] [Abstract][Full Text] [Related]
2. UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt/β-catenin pathway.
Wen JL; Wen XF; Li RB; Jin YC; Wang XL; Zhou L; Chen HX
PLoS One; 2015; 10(2):e0115622. PubMed ID: 25658088
[TBL] [Abstract][Full Text] [Related]
3. UBE3C promotes proliferation and inhibits apoptosis by activating the β-catenin signaling via degradation of AXIN1 in gastric cancer.
Zhang Y; Xu J; Fu H; Wei Z; Yang D; Yan R
Carcinogenesis; 2021 Feb; 42(2):285-293. PubMed ID: 32930707
[TBL] [Abstract][Full Text] [Related]
4. LINC00963-FOSB-mediated transcription activation of UBE3C enhances radioresistance of breast cancer cells by inducing ubiquitination-dependent protein degradation of TP73.
Wang Y; Liu M; Liu X; Guo X
J Transl Med; 2023 May; 21(1):321. PubMed ID: 37173692
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7.
Pan SJ; Zhan SK; Ji WZ; Pan YX; Liu W; Li DY; Huang P; Zhang XX; Cao CY; Zhang J; Bian LG; Sun B; Sun QF
Sci Rep; 2015 Jun; 5():11066. PubMed ID: 26067607
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells.
Tang L; Yi XM; Chen J; Chen FJ; Lou W; Gao YL; Zhou J; Su LN; Xu X; Lu JQ; Ma J; Yu N; Ding YF
Oncotarget; 2016 Mar; 7(13):15738-46. PubMed ID: 26894856
[TBL] [Abstract][Full Text] [Related]
7. Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications.
Dharavath B; Butle A; Chaudhary A; Pal A; Desai S; Chowdhury A; Thorat R; Upadhyay P; Nair S; Dutt A
NPJ Precis Oncol; 2024 Mar; 8(1):63. PubMed ID: 38438481
[TBL] [Abstract][Full Text] [Related]
8. G-Protein-Coupled Receptor 5 (LGR5) Overexpression Activates β-Catenin Signaling in Breast Cancer Cells via Protein Kinase A.
Chen Z; Xue C
Med Sci Monit Basic Res; 2019 Jan; 25():15-25. PubMed ID: 30662060
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
10. Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.
Satriyo PB; Bamodu OA; Chen JH; Aryandono T; Haryana SM; Yeh CT; Chao TY
J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30691241
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
[TBL] [Abstract][Full Text] [Related]
12. BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer.
Zhu L; Pan R; Zhou D; Ye G; Tan W
Cancer Manag Res; 2019; 11():2997-3007. PubMed ID: 31114347
[No Abstract] [Full Text] [Related]
13. Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3β/β-catenin signaling pathway in breast cancer.
Li K; Ma YB; Zhang Z; Tian YH; Xu XL; He YQ; Xu L; Gao Y; Pan WT; Song WJ; He X; Wei L
Cancer Med; 2018 Aug; 7(8):3875-3888. PubMed ID: 29968965
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
16. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
17. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
18. Restoration of GATA4 expression impedes breast cancer progression by transcriptional repression of ReLA and inhibition of NF-κB signaling.
Han X; Tang J; Chen T; Ren G
J Cell Biochem; 2019 Jan; 120(1):917-927. PubMed ID: 30187949
[TBL] [Abstract][Full Text] [Related]
19. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
20. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
